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Abstract 
An Examination of Prospective Memory in Multiple Sclerosis: A Theoretical Approach 
Using Objective and Subjective Measures 
Joshua D. McKeever 
Maria T. Schultheis, Ph.D 
 
 
Objective:  Prospective Memory (PM) is the ability to complete a task at some specific 
point in the future without constant rehearsal. PM is noteworthy for the impact it may 
have on everyday functioning in patient populations, but it is difficult to assess using 
objective neuropsychological tests, and thus self-report has commonly been used as a 
measure of PM function. One problem with this method of assessment is the lack of a 
theoretical basis for current measures, especially in light of the many recent advances 
toward a theory of PM. Individuals with Multiple Sclerosis (MS) are often high-
functioning, but 50-72% suffer from some form of cognitive impairment, especially in 
cognitive domains thought to be essential to PM. The goals of the current study were to 
a) use a theoretically-based approach to examining PM in the MS population, using 
objective and subjective measures of PM; and b) assess the usefulness of a novel measure 
of subjective PM problems (the Prospective Memory Complaints Questionnaire 
(PMCQ)) in the MS population. 
Participants:  Twenty-seven individuals with MS and twenty healthy controls, matched 
on distributions of gender, age, and education level.  
Methods:  Participants underwent a series of 3 measures, which included 1) a novel self-
report questionnaire (the PMCQ) assessing PM difficulties administered in an interview 
format; 2) a standardized, objective measure of PM (the MIST); and 3) a theoretically-
based experimental PM task (the Complex Prospective Memory (CPM) task). 
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Demographic variables, depression level, fatigue, quality of life, and level of MS 
symptom severity were also collected. 
Results: No significant between-group differences were found in performance on any of 
the objective and subjective measures of PM in the MS vs. HC groups. Within-groups 
analyses indicated that distinct factors in each group predicted objective PM (MIST) 
performance, and factors related to the utility of both the CPM task and the PMCQ (and 
the underlying theoretical model of each) were identified. 
Discussion: Overall, the current study demonstrated discrepant predictors of PM 
performance in MS and HCs, despite nonsignificant overall differences in performance 
when controlling for significant psychosocial and symptom severity factors. While much 
further research is needed to isolate the factors impacting PM performance in the MS 
population, the usefulness of a theoretical model of PM was demonstrated, as was the 
utility of examining PM using both performance-based and self-report measures.   
 
 
 
 
   
 
 
1  
1. INTRODUCTION 
1.1 Specific Aims 
 The overarching goal of this research project was to examine impairments in 
Prospective Memory (PM) and inform a more comprehensive depiction of functional 
impairment in individuals with Multiple Sclerosis (MS). It is hoped that this enhanced 
patient profile will help to improve clinical judgments. Prospective Memory, or the 
ability to realize future intentions, has emerged in the literature as an important function 
that concerns the practical uses of a particular constellation of cognitive abilities. PM is 
especially notable for the influence it may have on everyday functioning and basic well-
being, especially in patient populations that often have significant PM demands (e.g., 
medication adherence) concomitant with reduced capacity for the cognitive abilities 
which may be required for successful PM (Kliegel, Jager, Altgassen, & Shum, 2008). 
While the consequences of inadequate PM function can be disruptive, it is rarely assessed 
in clinical practice, and there is relatively little research available regarding the nature 
and consequences of PM deficits in distinct patient populations. PM has also proven 
difficult to assess using objective neuropsychological tests, and thus patient self-report 
has been proposed as a valuable supplement to (or substitute for) objective measures 
(Thone-Otto & Walthier, 2008). 
Because individuals with MS frequently have a neuropsychological profile that 
includes generally intact everyday functioning concurrent with some cognitive deficits, 
this population is particularly appropriate to examine in terms of PM impairments. 
Between 50 and 72% of individuals with MS experience cognitive impairment in wide-
ranging domains (Bobholz & Rao, 2003; Shevil & Finlayson, 2006). The population of 
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MS sufferers is relatively young and active compared with many other neurocognitively 
impaired populations, and individuals with MS are often keenly aware of their cognitive 
difficulties (Malcomson, Lowe-Strong, & Dunwoody, 2008; Marrie, Chelune, Miller, & 
Cohen, 2005; Yorkston, Johnson, Klasner, Amtmann, Kuehn, & Dudgeon, 2003). The 
current project aimed to 1) initiate a systematic approach to examining PM in the MS 
population, using a theoretical model (Kliegel, Mackinlay, & Jager, 2008), objective 
measures of PM (the Memory for Intentions Test (MIST) and an experimental paradigm, 
the Complex Prospective Memory Task), and a novel subjective measure of PM (the 
Prospective Memory Complaints Questionnaire (PMCQ)); and 2) collect user feedback to 
begin to validate a newly-developed questionnaire (the PMCQ) that seeks to gather and 
analyze self-reported PM difficulties. 
1.2 Background: Prospective Memory and Everyday Functioning 
 Prospective Memory (PM) is the term that has been traditionally applied to the 
concept of realizing delayed, or future, intentions. As Freud pointed out more than one 
hundred years ago, the factors inherent in both our successful and unsuccessful attempts 
at accomplishing future objectives are often a mystery to us (Freud, 1901). More recently, 
research has begun to explore the complex stages of processing that must usually occur to 
successfully complete a delayed objective. Researchers such as Burgess, Dumontheil, 
Gilbert, Okuda, Scholvinck, & Simons (2008) and Moscovitch (2008) discuss PM as a 
function rather than a construct. The difference, they maintain, is that a function is a set 
of context-dependent real-world behaviors that relies on multiple subordinate constructs, 
such as attention and working memory, which are more specialized cognitive processes 
(Burgess et al., 2008). Thus, research on prospective memory as a function is (or should 
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be) more concerned with the practical, everyday uses of the functional ability rather than 
focusing on component cognitive constructs, which may not provide a truthful picture of 
the purpose and process of cognitive abilities (Moscovitch 2008). 
 As one might expect, these “practical uses” are countless, and PM demands occur 
across the breadth of everyday human experience. Activities of daily living (ADLs), such 
as paying bills on time, often require intact PM abilities, as do many occupational (e.g., 
attending meetings and appointments, multitasking), social (e.g., returning messages from 
friends or picking someone up at the airport), and health-related (e.g., medication 
adherence or attending medical appointments) activities. PM requirements, and their 
chance of success or failure, are complicated by general conditions in one’s life, 
especially those (such as raising children) in which extremely complex multitasking 
becomes of central importance (Burgess et al., 2008). Failure in any of the above 
domains is by no means homogeneously significant to one’s life, but runs the gamut from 
being “highly embarrassing…[or] frustrating” to “life-threatening” (Kliegel, Jager, et al., 
2008, p. 284). In healthy individuals, the occasional PM failure is likely only to 
inconvenience oneself or cause others to become annoyed, while in many patient 
populations, tasks such as managing complex medication regimens are essential to health 
and safety, and poor PM function imposes extra responsibilities on caregivers (Kliegel, 
Jager, et al., 2008). 
1.2.1 A Theoretical Model of Prospective Memory 
The complexity of PM function necessitates establishing a theoretical framework 
to guide hypotheses. Several models, most coming from the cognitive psychology 
literature,  have been suggested to explain how PM occurs, including Shallice and 
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Burgess’s (1991) Supervisory Attentional System (SAS) theory, the Preparatory 
Attentional and Motivational Processes theory (PAM; Smith & Bayen, 2004) and 
Kliegel, Martin, McDaniel, and Einstein’s Multi-Phasic Process framework (Kliegel, 
Mackinlay, & Jager, 2008; Kliegel, Martin, McDaniel, and Einstein, 2002). Most 
research concerning the cognitive process of PM focuses on what has been termed the 
“initiation” of the delayed intention. In other words, both the SAS and the PAM theories, 
along with most laboratory investigations of PM, are most concerned with how it is that 
one becomes aware that it is time to enact one’s intention (Hertzog, 2008; Simons, 
Scholvinck, Gilbert, Frith, & Burgess, 2006). To this end, these theories often focus on 
the distinction between time-cued and event-cued PM tasks, since different aspects of 
environmental monitoring may be involved when one’s task must be initiated at a 
specific time (e.g., pick up a friend at the airport at 7:15) rather than in response to a 
specific event (e.g., stop to buy milk when passing a convenience store).  
While the “initiation” aspect of PM is clearly an integral step in the process of 
realizing a delayed intention, it is neither the only time when PM errors can occur nor 
necessarily the most important point in the process, although it has apparently proven to 
be the most convenient to study. In contrast, Kliegel, Martin, McDaniel, and Einstein’s 
(2002) Multi-Phasic Process model, while broader and potentially more difficult to 
examine empirically in a single study, seeks to specify all of the stages of processing that 
are required for successful PM. The stages of this model include Intention Formation 
(forming a plan of what is to be enacted), Intention Retention (retaining the intention in 
memory), Intention Initiation (recognizing the circumstances in which the intention 
should be performed), and Intention Execution (actual performance of the intention) (see 
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Figure 1 for a graphical representation). A major strength of this model is that it 
speculates as to what cognitive constructs may contribute to PM function at each stage. 
Despite fairly extensive inquiry in the literature, the word “speculate” may still be apt. 
Though there is general agreement on what component constructs are likely to contribute 
to each stage of PM, studies of patients who perform well on neuropsychological 
measures of these constructs but poorly on measures of PM are not uncommon (Burgess 
et al, 2008; West, McNerney, & Krauss, 2007). 
 The most common component constructs mentioned in the literature, according 
to which stage of the multi-phasic model they are thought to influence, are outlined in 
Figure 1. Intention formation is thought to rely on planning abilities and encoding 
efficiency or processing speed. Retrospective episodic memory is the key ability 
underlying intention retention. As was mentioned previously, intention initiation has been 
the most thoroughly studied stage, and is likely to require some combination of 
monitoring, cognitive flexibility, attention, and especially executive function. Intention 
execution has been correlated with inhibition and nonverbal fluency (Burgess et al., 2008; 
Kliegel, Jager, et al., 2008; Kliegel, Mackinlay, et al., 2008).  
Perhaps the most useful aspect of the Multi-Phasic Process model is that when 
PM failures occur, the (relatively more) specific stages or component of the failure can be 
identified and analyzed. Much more research is needed to determine both the accuracy of 
this model with regard to true PM function and what underlying constructs are important 
to each step in the process (e.g., executive planning to Intention Initiation, or inhibitory 
control to Intention Initiation) (Kliegel, Jager et al., 2008). However, it is the expansive 
scope of the Multi-Phasic Process theory that makes it extremely valuable to a 
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preliminary investigation of PM.  
 
 
Figure 1: Cognitive Components of Prospective Memory Multi-Phasic Model 
 
1.2.2 Measuring Prospective Memory 
 There is remarkably little to say with regard to assessing PM, because there are 
almost no standardized measures to do so. While there are nearly as many experimental 
PM paradigms as there are PM experiments, these experimental paradigms are often 
Example from Kliegel, Mackinlay, et al. (2008). Model components from Kliegel, Jager, et al. 
(2008); Kliegel, Mackinlay, et al. (2008); and Burgess et al. (2008). 
Component Construct Example Stage 
Intention Retention 
Intention Initiation 
Intention 
Formation 
Intention 
Execution 
Planning 
Processing Speed 
Retrospective Memory 
Monitoring 
Cognitive Flexibility 
Attention 
Executive Function 
Nonverbal Fluency 
Inhibition 
Forming plan to take 
medication after dinner 
Retaining goal details 
in memory during 
dinner without constant 
rehearsal 
Initiating goal on one’s 
own at the correct time 
(right after dinner) 
Executing goal based on 
plan (actually taking 
medication) 
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time-consuming and hardware-intensive, and their psychometric properties are rarely 
reported; thus, while very useful in empirical investigations of the theoretical bases of 
PM, they may not be particularly useful clinically (Kliegel, Jager, et al., 2008). 
Unfortunately, while experimental paradigms often have strong theoretical foundations, 
the same cannot be said for even the more popular PM assessment tools (Thone-Otto & 
Walthier, 2008). The Rivermead Behavioral Memory Test (RBMT; Wilson, Cockburn, & 
Baddeley, 1985) includes two PM tasks, but these have only been standardized in the 
context of the entire test, and thus a PM score is not easily obtained.  Two recently-
developed measures that have shown promise are the Cambridge Test of Prospective 
Memory (CAMPROMT; Wilson, Emslie, Foley, Shiel, Watson, Hawkins, et al., 2005) 
and the Memory for Intentions Test (MIST; Raskin & Buckheit, 2010). Each takes less 
than an hour to administer, consists of both time-cued (e.g., “Switch to another pen in 7 
minutes…”) and event-cued (e.g., “When I hand you a red pen…”) tasks, and has been 
standardized, although the CAMPROMT’s standardization is more comprehensive at this 
point (Thone-Otto & Walthier, 2008). Both of these tests show potential but suffer from 
inadequate theoretical support and lack of standardization in patient groups other than 
TBI (Kliegel, Jager, et al., 2008).  
 The limited number of well-validated, clinically useful PM assessment tools is 
partly due to the unique challenges posed by the complexity of PM function and our lack 
of understanding of the cognitive correlates of successful PM. A binary assessment of a 
PM task attempt (i.e. the success or failure of the intended action) confers only a limited 
picture of PM function, and thus objective measures such as the CAMPROMT and the 
MIST must be supplemented with a close examination of the patient’s daily functioning, 
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which may be difficult to obtain (Thone-Otto & Walthier, 2008). A thorough analysis of 
the specific cause of a PM failure (using an empirically-based theoretical model) would 
give clinicians insight into a patient’s clinical profile (Kliegel, Jager et al., 2008; Ellis & 
Freeman, 2008). To this end, it has been suggested that questionnaires may be effective 
means by which to assess PM function while retaining the context of the behavior.  
Questionnaires are currently the most commonly-used procedure for evaluating PM 
(Thone-Otto & Walthier, 2008). However, the degree to which even the more popular 
PM questionnaires actually measure current conceptions of PM is debatable. Often they 
include tasks that are no longer thought to fit under the rubric of PM (such as 
remembering to brush one’s teeth, which is a more routine, crystallized task; see the 
Comprehensive Assessment of Prospective Memory; Waugh (1999)) or focus only on 
specific components of PM, such as memory for the details of the intention (the 
“retrospective component;” see the Prospective and Retrospective Memory 
Questionnaire; Smith, Della Sala, Logie, & Maylor, 2000). The major disadvantage of all 
self-report measures is the potential for inaccurate reporting, which is even more of a 
concern in cognitively impaired populations. However, authors of both reviews (Thone-
Otto & Walthier, 2008) and empirical studies (Crawford, Henry, Ward, & Blake, 2006; 
Hannon, Adams, Harrington, Fries-Dias, & Gipson, 1995) support the use of 
questionnaires as measures of PM in particular. In any case, self-report measures of PM 
surely provide the clinician with information that may not be available from objective 
cognitive tests alone (Sullivan, Edgley, & Dehoux, 1990). 
Currently, prospective memory is not commonly assessed in clinical contexts, 
despite the fact that problems completing delayed intentions are frequently noted in 
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numerous patient populations. As Kliegel, Jager, et al. (2008) illustrate in their excellent 
overview of investigations of PM in clinical populations, a wide range of patient groups 
have been examined in terms of potential PM deficits, including substance abuse, 
psychiatric disorders, developmental disorders, viral infections, and neurological 
disorders. The results of these studies are enlightening and contribute considerably to 
exposing PM as a significant problem in clinical populations. A closer look at their 
survey, however, reveals the lack of depth in the clinically-based PM literature. Outside 
of dementia and TBI, no disorder has garnered more than a handful of publications that 
focus on PM impairments. The studies that do exist employ a variety of methods (usually 
experimental paradigms) to examine PM, many of which fall far short of today’s 
standards or include manipulations that are no longer believed to be valid. This 
deficiency of research is surprising, given the sheer number of disorders associated with 
cognitive deficits that putatively contribute to PM ability (Kliegel, Jager et al., 2008).  
1.3 Background: Multiple Sclerosis and Associated Cognitive Deficits 
Multiple Sclerosis (MS) is thought to be an autoimmune disease in which the 
sufferer’s immune system attacks the myelin sheath of neurons in the central nervous 
system, causing diffuse white matter damage and widespread disruption of neural 
transmission. Symptoms of the disease are extremely varied, but generally fall into the 
broad categories of motor impairments, sensory impairments, emotional problems, bowel 
and bladder difficulties, and cognitive impairments, as well as pain and fatigue. Several 
subtypes of the disease have been identified based on the rate and pattern of progression, 
which usually happens in discrete episodes called relapses or exacerbations.  Prevalence 
rates for MS vary; a 2001 study of worldwide MS prevalence by Rosati found rates 
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between 2 and 150 per 100,000, but it is generally agreed that MS is one of the most 
common neurological diseases of early and middle adulthood (Engel, Greim, & Zettl, 
2007). Because MS sufferers are relatively young and active compared with many other 
neurocognitively impaired populations, they often retain a strong desire to be active and 
engaged in work and other activities. A significant portion of the MS population is in the 
prime of their working lives (in terms of age), and several studies have looked 
qualitatively at these individuals’ perceptions of their occupational limitations. Even if 
“work” is given the broader definition of any activity done to accomplish some goal 
despite obstacles, it is clear that ability to work and maintain productivity is a major 
concern for this population. Many of their concerns are related to the presence or 
anticipation of cognitive decline (Malcomson, Lowe-Strong, & Dunwoody, 2008; Shevil 
& Finlayson, 2006; Yorkston, Johnson, Klasner, Amtmann, Kuehn, & Dudgeon, 2003). 
 Although MS is noteworthy because of the sheer number of potential symptoms, 
researchers have recently become increasingly interested in the cognitive symptoms of 
the disorder. There is some disagreement about the prevalence of cognitive impairments 
in MS; the common belief seems to be that roughly 50% have impairments (Bobholz & 
Rao, 2003), but other estimates are as high as 72% (Shevil & Finlayson, 2006). Memory 
difficulties are a common finding and include retrospective memory (in this case 
encompassing short term and long term memory) and working memory (Thornton & Raz, 
1997). Other domains shown to be impaired include processing speed and immediate 
memory (Marrie, Chelune, Miller & Cohen, 2005), attention, visuospatial abilities, and 
executive abilities (Engel, Greim, & Zettl, 2007; Bobholz & Rao, 2003).  
 It is also worth bearing in mind that MS, by definition, affects tissue throughout 
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the central nervous system. While it has traditionally been thought to affect mainly the 
white matter, recent investigations have implicated deep grey matter structures as well, 
including medial temporal lobe structures and the thalamus (Benedict, Ramasamy, 
Munschauer, Weinstock-Guttman, & Zivadinov, 2009). Benedict et al. (2009) 
demonstrate the detrimental effects of frontal-subcortical axis degeneration on memory, 
processing speed, and visual perception. This study provides evidence of the 
consequences of damaged neural connections, which may especially (or exclusively) 
impair functions that rely on separate structures working in concert.  
1.3.1 Background: Prospective Memory in Multiple Sclerosis 
Given the range of cognitive deficits demonstrated in MS, and considering the 
apparent contributions of most of these cognitive abilities to PM, it is not unreasonable to 
expect PM deficits in individuals with MS. This has been found to be the case in the very 
few studies that have examined PM function in MS (see Kliegel, Jager, et al., 2008, for a 
review; Bruce, Hancock, Arnett, & Lynch, 2010; Kardiasmenos, Clawson, Wilken, & 
Wallin, 2008; Rendell, Jensen, & Henry, 2007; Bravin, Kinsella, Ong, & Vowels, 2000). 
Interestingly, even studies that have ruled out deficits in component constructs have 
identified PM problems (Rendell, Jensen, & Henry, 2007), and West, McNerney, & 
Krauss (2007) reported a case study of a potential circumscribed PM deficit in an 
individual with MS. These findings are puzzling but speak to the complexity of PM 
function as more than the sum of its parts, as well as to the need for further study in 
patient groups such as MS and more sensitive (and perhaps population-specific) measures 
of PM. 
In light of the earlier discussion regarding the use of self-report measures to 
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assess PM function, and the complications inherent in such an assessment, the fact that 
individuals with MS are often keenly aware of their cognitive difficulties is worthy of 
mention. Many would argue, and logic dictates, that a memory-impaired person is not 
able to accurately perceive his or her own memory deficit, and this phenomenon is 
apparent in cognitively-impaired patient populations such as patients with Alzheimer’s 
disease. However, at the early stages of decline, cognitive impairments that are too subtle 
to be picked up by neuropsychological (and also, importantly, imaging) study may be 
evident to the patient themselves in a subjective sense. Marrie et al.’s 2003 study using 
136 individuals with MS showed that there is an intriguing, and non-linear, relation 
between cognitive decline and subjective memory complaints (as measured by a self-
report memory inventory), in that those with the fewest deficits (i.e. normal function) and 
those with the most deficits (i.e. severe impairments) are unlikely to report subjective 
cognitive complaints, whereas individuals with mild impairments are able to accurately 
report on their experience. Of special note, this study also controlled for depression, 
which is associated with subjective cognitive complaints across patient populations (and 
probably in the general population as well). Additionally, the authors controlled for 
fatigue and physical impairment, both of which are particularly important issues in the 
MS population (Marrie et al., 2003). The fact that these authors were able to tease apart 
such significant and interrelated factors is remarkable. 
Several other studies have corroborated Marrie et al.’s (2003) assertion that 
individuals with MS can be relied upon to provide accurate information regarding their 
deficits. Studies by Solari, Amato, Bergamaschi, et al. (1993) and Goodin (1996) showed 
that patient self-report of deficits predicted performance on objective scales of 
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impairment. More recently, Benedict & Zivadinov (2006) developed and used the 
Multiple Sclerosis Neuropsychological Screening Questionnaire (MSNQ) as a brief, 
reliable screening tool for cognitive and psychiatric dysfunction in MS. The measure 
includes both patient and informant forms, and in their 2006 study, scores on both forms 
significantly correlated with patient performance on a battery of neuropsychological tests. 
A previous study by this group using the same questionnaire had failed to find 
correlations between patient-report and objective test performance, but did find 
correlations with informant report (Benedict, Munschauer, Linn, Miller, Murphy, Foley, 
& Jacobs, 2003). Bruce, Bruce, Hancock, & Lynch (2010) found that perceived memory 
impairment was not associated with any neuropsychological testing measure, but that the 
relationship was mediated by dissociative experiences. As these examples indicate, 
findings in these types of studies are not perfectly consistent, and the studies which have 
found subjective reports of individuals with MS to be reliable are by no means 
conclusive. While studies such as these are potentially limited by the inclusion of 
participants with more serious impairments, they specify the need to use caution when 
interpreting the results of subjective assessments of cognitive impairment, with increased 
caution required as impairment levels increase. 
1.4. Significance of the Present Study 
 The current study sought to initiate a systematic approach to examining PM in the 
MS population, using a Multi-Phasic Process-based theoretical model (Kliegel, 
Mackinlay, et al. 2008; Kliegel, et al., 2002). It was hoped that the use of this model as 
the basis for PM assessment would facilitate the collection of specific information 
regarding exactly what skills or components influence a patient’s PM performance; thus, 
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for example, if a patient has the most trouble with the “intention initiation” stage of PM, 
we may be able to rule out selective retrospective memory problems as the underlying 
cause of a patient’s PM difficulties and focus on what abilities may have a greater 
contribution, such as attention or executive function.   
Before clinicians can appropriately interpret the results of PM assessment using 
self-report and/or neuropsychological testing, it is important to understand to what degree 
PM failures are truly problematic for individuals with MS. The MS population is an ideal 
one with which to assess subjective PM complaints due to the reasons described above: 
they are often young and engaged (and thus have many PM demands), are frequently 
well-aware of their cognitive deficits (thus, self-report should be reliable), and suffer 
from a constellation of cognitive symptoms that are likely to be integral to successful PM 
(thus, we can expect PM deficits in many individuals with MS). To gather preliminary 
information regarding PM impairments, the Applied Neuro-Technologies Laboratory has 
developed a questionnaire to capture detailed information regarding specific PM 
difficulties in the MS population. Previous studies of this type, as well as previous 
subjective PM measures, have suffered from poor theoretical support and insufficient 
attention given to the full range of potential cognitive correlates of PM. To address these 
concerns, the Prospective Memory Complaints Questionnaire (PMCQ) was developed as 
a theoretically-based measure designed to garner information regarding the frequency of 
PM problems, how personally significant these problems are, and what particular stages 
of processing are most important when failures occur in individuals with MS (see Figure 
2 for a sample item; see Appendix A for the complete questionnaire). The preliminary 
information gathered with this measure is an important first step to characterizing PM 
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difficulties in MS, and healthy controls also completed the survey to determine whether 
PM problems in the MS population are quantitatively and/or qualitatively different than 
PM problems in healthy adults. Additionally, in this study we began to examine the 
relation between subjective reports and objective measures of PM by comparing self-
report data to a standardized measure of PM function as well as a theoretically-based 
experimental PM paradigm, the Complex Prospective Memory Task. The current study 
represents the first investigation to systematically assess subjectively-reported 
impairments in PM based on a process model, in any patient group. The overarching goal 
is to use information about PM impairments to inform a more comprehensive depiction 
of functional impairment in MS in order to improve clinical judgments. 
 
Figure 2: PMCQ Sample Item 
 
 
 
 
 
I did not take out the garbage on trash day, even though it needed to go out.  
 A                              Please rate how often this has occurred in the last month 
0 1 2 3 
Never Sometimes Often Almost Always 
  B  I did not take out the garbage on trash day, even though it needed to go out 
because… 
 □ I did not make a plan to take the garbage out 
 □ I forgot some important detail about trash day 
 □ I did not take out the garbage in time 
 C                                            Please rate how distressing this was to you 
0 1 2 3 
Not at all distressing A bit distressing Moderately distressing Very distressing 
16  
 
2. METHODS 
2.1 Study Overview 
 This study was a preliminary exploration of PM difficulties in a sample of 
individuals with MS as compared to healthy controls. Data was collected during a two-
hour study visit in which individuals with MS and controls completed a standardized 
objective PM assessment, an experimental PM paradigm, and a new self-report measure, 
the Prospective Memory Complaints Questionnaire (PMCQ) in an interview format. 
Demographic information and several measures of psychosocial function were also 
collected, including information pertaining to each patient’s MS diagnosis. The primary 
goal of the current study was to use theoretical rationale to characterize PM problems in 
individuals with MS, using both objective and subjective measures of PM. A secondary 
goal was to assess the usefulness of the PMCQ as a measure of everyday PM function. 
2.2 Participants 
The groups consisted of a sample of individuals with diagnosed MS of any type 
(N = 27), and a sample of healthy controls (HCs; N = 20). 
2.2.1 Recruitment 
 The MS participants were recruited from local chapters (PA and NJ) of the 
National Multiple Sclerosis Society and a local neurology clinic, as well as from a 
database of individuals with MS involved in other studies in the Applied Neuro-
Technologies Lab. Healthy Control participants were recruited through flyers posted 
locally and given to former lab participants, and from a database of HC individuals 
involved in other studies in the Applied Neuro-Technologies Lab. All participants were 
required to be between 21 and 60 years of age, because of the rarity of receiving an MS 
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diagnosis before 21 and to reduce the potential effects of aging on cognitive performance.  
Participants had to meet the following exclusion criteria: 1) no significant alcohol/drug 
history, defined by current treatment or hospitalization; 2) no significant neurological 
diagnosis, defined by diagnosis and/or treatment of a major neurological illness (e.g. TBI, 
seizure disorder); 3) no significant psychiatric history, defined by diagnosis and/or 
treatment of a major psychiatric illness (e.g., bipolar disorder).  MS participants were 
required to have carried their diagnosis of MS for at least one year, must not have had a 
relapse within the past 30 days and could not have been undergoing steroid treatment, 
because of the probability of acute symptoms during these periods and the influence of 
these medications on cognitive performance.  
In the MS group, twenty-seven out of 33 individuals who underwent initial 
assessment protocol met the inclusion and exclusion criteria specified previously and 
consented to participate in the study. In the HC group, 20 out of 47 individuals who 
underwent initial assessment proceeded to study enrollment. Of the MS individuals not 
meeting criteria, one individual exceeded the age requirement, and two individuals were 
not on a stable regimen of medications. Three individuals met criteria to participate, but 
declined entry into the study. Of the HC individuals, 27 individuals were excluded 
because they were unsuitable matches for the MS sample, either because of age (i.e., too 
young) or gender (i.e., male). 
2.2.2 General demographics  
The MS sample consisted of 27 participants with a diagnosis of MS confirmed 
through participants’ treating neurologist.  The sample was 96% female (n = 26) and 4% 
male (n = 1), relatively consistent with reported gender differences in MS disease 
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prevalence, indicating higher rates among females (Milo & Kahana, 2010).  Participants’ 
mean age was 47.7 years (SD = 7.90), and mean education was 15.2 years (SD = 2.20).  
The sample was 85.2% Caucasian (n = 23), 7.4% African-American (n = 2), and 7.4% 
Hispanic (n = 2), consistent with reports of higher MS disease prevalence in Caucasian 
individuals.  
The HC sample consisted of 20 participants without a diagnosis of MS.  The 
sample was 95% female (n = 19) and 5% male (n = 1).  Participants’ mean age was 48.8 
years (SD = 8.37), and mean education was 15.6 years (SD = 2.44).  The sample was 
65.0% Caucasian (n = 13) and 35.0% African-American (n = 7). 
2.2.1 Power Analysis  
The proposed project was a preliminary and exploratory analysis. To satisfy one 
of the primary objectives, to characterize PM deficits in individuals with MS as compared 
to healthy controls, we employed separate methods to analyze results of the objective and 
subjective PM measures. To examine group differences in PM functional assessment 
(MIST) scores, planned analyses included an independent-samples t-test. Based on a 
power analysis using the program G*Power (Faul, Erdfelder, Buchner, & Lang, 2009) 
and the average calculated effect size from the three available studies which examined 
PM in MS (Kardiasmenos et al., 2008; Rendell et al., 2007; Bravin et al., 2000), and 
assuming an alpha of .05 and power of .80, 27 participants were projected to be required 
in each group to obtain statistical significance. To examine group differences in 
subjective PM ratings, planned analyses included an independent-samples t-test using 
scores from the Frequency scale of the PMCQ (see Section 2.3.2, below). Based on 
objective PM assessment data (since this type of analysis has not been conducted 
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previously), a medium effect size (identical to that expected in the previous analysis) with 
an alpha of .05 and power of .80, it was estimated that this analysis would also require 27 
participants per group to obtain statistical significance.  
Though the preceding power analyses do not address all of the analyses conducted 
in the current investigation (see Section 2.5, below), they do address all analyses that 
have any previous literature whatsoever on which to derive effect size estimates. Thus, 
based on the results of this power analysis, the target group size was 27 per group.  
2.3 Assessment Measures 
A list of all planned assessment measures is provided in Table 1. 
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Table 1: Test Battery 
Measure Description Reference 
Neuropsychological tests   
Memory for 
Intentions Test (MIST) 
The MIST is a test of eight prospective memory tasks. Each of the eight 
tasks is similar to a real-world task that one might have to perform in daily 
life. It includes both time- and event-cued tasks, and both long and short 
time delays. It also includes a 24-hour delayed task. It is particularly 
appropriate for individuals with neurological disorders. 
Raskin & 
Buckheit, 2010 
Complex Prospective 
Memory Task (CPM) 
The Complex Prospective Memory Task is a research paradigm using a 
modified version of the Six Elements Test first proposed by Shallice and 
Burgess (1991), in which participants have six minutes to perform two 
parallel versions of three types of tasks. The PM-specific modifications 
include manipulations in which participants are asked to explicitly plan 
their strategy in advance, recall their plan when prompted, and self-initiate 
the task at a specified time. 
Kliegel, 
McDaniel, & 
Einstein, 2000 
Multiple Sclerosis 
Functional Composite 
(MSFC) 
The Multiple Sclerosis Functional Composite (MSFC) is a composite score 
composed of three measures of functions commonly impaired in MS: lower 
extremity function (measured with the Timed Walk Test (TWT)), upper 
extremity function (measured with the Nine-Hole Peg Test (9-HPT)), and 
cognitive function (measured with an MS-specific version (2- and 3-second 
trials) of the Paced Auditory Serial Additional Test (PASAT)). 
Fischer, 
Rudick, Cutter, 
& Reingold, 
1999), 
Questionnaires     
Prospective Memory 
Complaints 
Questionnaire 
(PMCQ) 
The PMQC consists of 25 items grouped into 4 domains: Medical/Health, 
Vocational, Social, and Everyday Activities. Each item describes a possible 
PM failure and asks participants to: a) rate how often this problem occurs 
for him or her, on a 0-3 scale; b) choose at which stage of processing the 
error occurred; and c) rate how distressing the failure was, on a 0-3 scale. 
Ratio scores (scale score / total items endorsed) will be computed for parts 
a and c, and responses to part b will be analyzed quantitatively.  
McKeever & 
Schultheis, 
unpublished 
Multiple Sclerosis 
Quality of Life-54 
(MSQoL-54) 
The MSQOL-54 is a 54-item questionnaire assessing health-related quality 
of life , and includes items that tap directly into the physical, social, sexual, 
and fatigue- and pain- related symptoms of MS. 
Vickrey et al., 
1995 
Beck Depression 
Inventory – II (BDI-II) 
The BDI-II contains 21 self-report items assessing depression symptom 
severity based on the DSM-IV criteria. Though neurovegetative symptoms 
of MS have been shown to elevate BDI-II score, evidence is equivocal, and 
research has shown that all BDI-II items do indeed tap depression in MS 
(Moran & Mohr, 2005). 
Beck, Steer, & 
Brown, 1996 
Fatigue Severity Scale 
(FSS) 
The FSS is a 9-item self-report inventory commonly used in individuals with 
MS to evaluate their subjective level of fatigue over the past week using a 
7-point Likert scale.  
Krupp et al., 
1989 
Visual Analog Scale of 
Fatigue (VAS-F) 
The VAS-F is a visual analogue scale used to assess levels of state fatigue. 
Participants mark their current level of fatigue on a line 10 centimeters 
long. It will be administered at the beginning and end of the testing day to 
monitor the effects of fatigue during testing. 
Kos et al, 2006 
 
 
 
2.3.1 Demographic Information 
Demographic variables of age, gender, occupational status, medications, and 
years of education were collected from all participants. Variables collected from MS 
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participants included MS subtype, duration of diagnosis, and duration of symptoms. HCs 
were selected to match the distributions of the MS group’s demographic variables (age, 
gender, and years of education only).  
2.3.2 Questionnaire (PMCQ) 
The Prospective Memory Complaints Questionnaire (PMCQ) was developed for 
this study because of the scarcity of theoretically-based and comprehensive measures of 
PM currently available. The measure consists of 25 items grouped into 4 domains: 
Medical/Health, Vocational, Social, and Everyday Activities. Each item describes a 
possible PM failure an individual might experience and asks respondents to a) rate how 
often this problem occurs for him or her; b) choose at which stage (see Kliegel, et al.’s 
(2002) model) the error occurred; and c) rate how distressing the failure was. It includes 
comprehensive instructions to ensure that respondents understand what is being asked, 
and includes a cover page to collect demographic information (age, type of MS, checklist 
of symptoms, etc.) as well as information regarding what strategies or external memory 
aids the respondent may commonly use (for an example of a PMCQ item, see Figure 2, 
above; see Appendix A for the complete questionnaire). In this preliminary study, the 
PMCQ was administered in an interview-type format. This decision was made due to the 
fact that this is the first time the measure was used, and extensive notes were taken 
regarding factors such as participant confusion about certain items in order to make 
adjustments and improve to the measure.  
The PMCQ was modeled after several previous PM self-report measures (Smith, 
Della Sala, Logie, & Maylor, 2000; Waugh, 1999; Hannon et al., 1995) and a previous 
memory questionnaire used in MS (Sullivan et al., 1990). However, the PMCQ is unique 
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in that it 1) was theoretically developed using the Multi-Phasic Process model of PM, 2) 
makes use of only the most current conceptions of PM tasks, and 3) includes a rating not 
only of the frequency of problems but also their personal significance to the respondent.  
Because there are three elements to each PMCQ item (see Figure 2), scoring of 
the PMCQ items was divided into several scales. The “Frequency” scale was calculated 
from the sum of responses to the frequency (A) element divided by the total number of 
responses to the overall questionnaire, to account for items that were not applicable to the 
respondent. The “Stage” scale consisted of three sub-scores, determined by the total 
number of endorsements on each of the three stage options (element B) (i.e., one score 
for the “form a plan” option (Plan sub-score), one score for the “forgot my plan” option 
(Recall sub-score), and one score for the “initiate my plan” option (Initiation sub-score)). 
The “Distress” scale was calculated, similarly to the Frequency scale, from the sum of 
responses to the distressfulness (C) element divided by the total number of responses to 
the questionnaire. Domain sub-scores were calculated separately for each of the four 
domains (Medical/Health, Vocational, Social, and Everyday Activities), and consisted of 
the sum of the endorsements from the Frequency (A) and Distress (C) elements for the 
set of items corresponding to each domain. The Medical/Health domain included 4 items, 
the Vocational domain included 6 items, the Social domain included 6 items, and the 
Everyday Activities domain consisted of 9 items.  
2.3.3 Complex Prospective Memory Task  
The Complex Prospective Memory (CPM) Task (Kliegel, McDaniel, & Einstein, 
2000) is a modified version of the Six Elements Test (mSET) first proposed by Shallice 
and Burgess (1991). Participants are given six minutes to perform two parallel versions of 
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three types of tasks (word task, arithemtic task, picture naming task) for a total of six 
tasks. Rules are given that govern how the tasks must be completed, but otherwise the 
manner in which the tasks are completed is up to the participant. The PM-specific version 
included manipulations in which participants were asked to explicitly plan their strategy 
in advance, recall their plan when prompted, and self-initiate the task at a specified time. 
Four scores are produced for the complete CPM task, corresponding to the four phases of 
PM (Intention Formation [Plan], Intention Retention [Recall], Intention Initiation 
[Initiation], and Intention Execution [Execution]). The Plan and Recall phases are 
verbally produced by the particpant and recorded, and the contents of each phase is 
scored based on criteria given in Kliegel, et al. (2000). The Initiation portion of the task 
requires participants to begin the mSET in response to a specific cue (after completing 
their date of birth on the Participant Information Form), and one point is given for a) 
remembering the correct task, and b) doing so at the correct time, for a maximum 
possible score of 2 points.  The Execution portion is simply the participant’s actual 
performance on the mSET task (part of the Behavioral Assessment of the Dysexcutive 
Syndrome battery; Wilson, Alderman, Burgess, Emslie, & Evans, 1996). 
2.3.4 Standardized Prospective Memory Measure 
To obtain an objective and standardized measure of PM function, the Memory for 
Intentions Test (MIST; Raskin & Buckheit, 2010) was administered. While it has been 
used in other patient populations, to our knowledge this test has been used only once in 
the MS population (Bruce, Hancock, Arnett, & Lynch, 2010). The MIST is a test of eight 
prospective memory tasks. Each of the eight tasks is similar to a real-world task that one 
might have to perform in daily life; for example, one item states, “in 2 minutes, ask me 
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what time this session ends today” (Woods, Moran, Dawson, Carey, & Grant, 2008). It 
includes both time- and event-cued tasks, and both long (15-minute) and short (2-minute) 
time delays. It is particularly appropriate for individuals with neurological disorders, and 
takes approximately 30 minutes to administer. 
 2.3.5 Other Measures 
Testing included several tests traditionally used to estimate the contribution of 
MS symptoms to neuropsychological test performance, as well as a measure of 
depression, which has been frequently noted to have a significant effect on self-report 
measures and be a concern for the MS population (Middleton, Denney, Lynch, & 
Parmenter, 2006). A general depiction of subjectively-reported MS symptom severity and 
its effects on quality of life was assessed with the Multiple Sclerosis Quality of Life-54 
measure (MSQOL-54; Vickrey, Hays, Harooni, Myters, & Ellison, 1995). Objective MS 
symptom severity was measured with the Multiple Sclerosis Functional Composite 
(MSFC; Fischer, Rudick, Cutter, & Reingold, 1999), which is a composite score 
composed of three measures of functions commonly impaired in MS: lower extremity 
function (measured with the Timed Walk Test (TWT)), upper extremity function 
(measured with the Nine-Hole Peg Test (9-HPT)), and cognitive function (measured with 
an MS-specific version (2- and 3-second trials) of the Paced Auditory Serial Additional 
Test (PASAT)). State and overall symptomatic fatigue were measured with the Visual 
Analog Scale of Fatigue (VAS-F; Kos, Nagels, D'Hooghe, Duportail, & Kerckhofs, 
2006) and the Fatigue Severity Scale (FSS; Krupp, LaRocca, Muir-Nash, & Steinberg, 
1989), respectively. Depression severity was measured using the Beck Depression Scale - 
II (BDI-II; Beck, Steer, & Brown, 1996). The FSS, BDI-II and MSQOL-54 were 
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completed at the end of the testing session. 
2.4 Procedures 
To determine eligibility, a pre-study phone screening interview was conducted. 
Using a predetermined script, the researcher asked several questions to ensure that all of 
the exclusion and inclusion criteria were met. Following the pre-screening phone 
interview, if eligible, the participant was invited to participate and given written informed 
consent including HIPAA approved by the Drexel University Institutional Review Board 
(IRB). After obtaining informed consent, eligible participants proceeded to study 
enrollment.  
All participants participated in one session lasting approximately two hours. All 
testing was conducted in the Schultheis Applied Neuro-Technologies Laboratory at 
Drexel University. At the beginning of the testing session, participants were administered 
an initial VAS-F scale to obtain a pre-testing rating of fatigue, and the Plan phase of the 
CPM task was then administered. Next, participants were asked to provide a brief 
medical and psychosocial history, followed by the measures composing the MSFC and 
the Recall phase of the CPM task. The PMCQ questionnaire interview then took place, 
followed by the remaining portions of the CPM task, followed by the MIST. The 
remaining questionnaires (the FSS, MSQoL-54, and BDI-II) were then completed. 
Participants were offered a short break after roughly one hour of testing, as long as it did 
not occur during a test-required delay. At the end of the study participants completed a 
final VAS-F, and were debriefed and compensated for their time.  
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2.5 Hypotheses and Plan of Analysis 
Preliminary analyses were conducted to compare demographic and psychosocial 
variables between the two groups and ensure an equal distribution of these variables. 
Independent-samples t-tests for continuous variables or chi-square tests of independence 
for categorical variables were used to examine whether the groups’ distributions differ 
significantly on these variables. When significant differences were found, these variables 
were used as covariates in subsequent analyses to control for their potential influence. 
Several changes from the original project proposal were instituted, most notably: a) 
hypotheses were refined and updated after reconsideration of the specificity/testability of 
the original text; b) because statistically significant differences between the groups were 
identified on psychosocial and symptom severity variables, Analyses of Covariance were 
employed instead of t-tests to statistically control for these variables; and c) where 
statistically significant differences were not identified between the groups on main study 
variables, additional analyses (stepwise linear multiple regressions) were employed to 
explore patterns of performance in each group separately.  
The data were checked to determine to what degree the assumptions for each 
statistical test were violated. If assumptions were not met, data transformations or other 
remedial procedures were undertaken to account for the violations. Analyses addressed 
the aims of the study. See Table 2 for a description of all study variables.  
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Table 2. Study Variables 
Measure/Variables Function Measured 
MIST  
    Total Score percentile (PMT%) Standardized objective PM performance 
CPM Task  
    Plan Stage Score Intention Formation stage performance 
    Recall Stage Score Intention Retention stage performance 
    Initiation Stage Score Intention Initiation stage performance 
    mSET Profile Score Intention Execution stage performance 
PMCQ  
    PM Aids used Self-reported (SR) # of PM aids used 
    Total Items Answered # of items endorsed as applicable to the participant 
    Frequency Scale Score SR PM error frequency† 
    Distress Scale Score SR PM error-related distress† 
    Plan Stage sub-score SR Intention Formation errors 
    Recall Stage sub-score SR Intention Retention errors 
    Initiation Stage sub-score SR Intention Initiation errors 
    Medical Domain sub-score SR medically-related item errors 
    Vocational Domain sub-score SR vocationally-related item errors 
    Social Domain sub-score SR socially-related item errors 
    Everyday Activities Domain sub-score     SR everyday activities-related item errors 
Questionnaires  
    FSS Average Score Average SR symptomatic fatigue 
    BDI-II Score SR Depression level 
    MS-QoL Overall QoL Overall SR quality of life 
    MS-QoL Physical Composite Score Overall SR physical symptom-related quality of life 
    MS-QoL Mental Composite Score Overall SR mental symptom-related quality of life 
MSFC Score MS symptom severity (composite score) 
† = Corrected for Total Items Answered 
 
Aim 1. To identify and define PM deficits in individuals with MS with 
respect to a theoretical model of PM using subjective and objective measures. 
Hypothesis 1: Individuals with MS perform more poorly on objective tests of PM 
than healthy controls.  
To examine objective PM performance, Analyses of Covariance (ANCOVAs) 
were performed to assess group differences in performance between the MS group and 
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the HC group on the MIST and on each portion of the CPM task. Analyses were covaried 
for depression (BDI-II score), fatigue (FSS Average Score), symptom severity (MSFC 
score), and quality of life (MSQoL-54 Overall Quality of Life). For the MIST, MIST 
Total Score percentile (PMT%) was used as the dependent variable. For the CPM task, 
Plan Score, Recall Score, Initiation Score and Execution Score (mSET Profile Score) 
were used as dependent variables. It was hypothesized that individuals with MS will 
score significantly lower on the MIST and significantly lower on the CPM tasks than 
HCs. 
Hypothesis 2: Individuals with MS self-report committing more subjective PM 
errors than healthy controls. 
To examine subjective PM performance, an ANCOVA was performed to assess 
group differences in self-ratings from the Frequency scale of the PMCQ between the MS 
group and the HC group. Analyses were covaried for depression (BDI-II score), fatigue 
(FSS Average Score), symptom severity (MSFC score), and quality of life (MSQoL-54 
Overall Quality of Life), and PMCQ Frequency Scale Score was entered as the dependent 
variable. It was hypothesized that individuals with MS would score significantly higher 
on the PMCQ-Frequency scale.  
Hypothesis 3: Individuals with MS self-report experiencing more subjective 
distress related to PM errors than healthy controls.  
To examine the significance of PM problems to participants, an ANCOVA was 
performed to assess group differences in self-ratings from the Distress scale of the PMCQ 
between the MS group and the HC group. Analyses were covaried for depression (BDI-II 
score), fatigue (FSS Average Score), symptom severity (MSFC score), and quality of life 
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(MSQoL-54 Overall Quality of Life), and PMCQ Distress Scale Score was entered as the 
dependent variable. It was hypothesized that individuals with MS would score 
significantly higher on the PMCQ-Distress scale. 
Hypothesis 4: Individuals with MS self-report a different pattern of PM Stage 
errors than healthy controls.  
To examine patterns of PM failures, a Bonferroni-corrected independent-samples 
t-test will be performed for each PMCQ Stage sub-score to assess group differences in 
self-ratings from the Stage scale of the PMCQ between the MS group and the HC group. 
Though research on the cognitive deficits in MS is inconclusive with regard to which 
stage of the multi-phasic process model is expected to be most impaired, some research 
has shown the retrospective component may be the most difficult for individuals with MS 
(Bravin et al., 2000). Thus, the preliminary hypothesis was that the MS group would 
endorse significantly more items from the Recall stage option, and no significant 
differences would be identified for the other two options. Additionally, because the 
PMCQ items are divided into four domains of functioning (Medical, Vocational, Social, 
Everyday Activities), t-tests will also be performed for each Domain sub-score to assess 
differences between the groups. 
Aim 2. To examine and improve the utility of the PMCQ as a subjective 
measure of PM. 
Hypothesis 5: The PMCQ will be a useful and appropriate measure of subjective 
PM function. 
To evaluate the usefulness of the PMCQ, qualitative user feedback will collected 
during PMCQ administration, and preliminary psychometric and qualitative 
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characteristics will be assessed. Though this is the first time the PMCQ has been 
employed in any population, and thus its value as a measure of PM is uncertain, previous 
research has established the usefulness of subjective report in estimating both PM 
function in varied patient groups and cognitive difficulties in the MS population. The 
current study was used as an opportunity to critically examine this novel measure and 
collect user feedback from participants during the testing session. 
 
3. RESULTS 
3.1 Analytical Strategy 
All analyses were performed using PASW 19.0.  Analyses in the current study 
used descriptive analyses, comparisons of group means, and stepwise multiple linear 
regression.  All between-group analyses used presence of MS diagnosis as the grouping 
variable (i.e., MS group versus Healthy Control (HC) group). Descriptive analyses were 
performed for demographic variables, neuropsychological variables, and psychosocial 
outcome variables.  Means and standard deviations (or percentage/frequencies for 
categorical variables) for variables of interest are reported for each group.  Demographic 
psychosocial, and symptom severity variables found to be statistically different across 
groups were entered as covariates in Analyses of Covariance (ANCOVAs) and in Block 
1 in stepwise regression analyses.  
Scores on the MIST were converted to standardized scores to facilitate 
examination of the distribution of scores.  The distribution of all variables was tested for 
normality using skewness and kurtosis statistical tests.  The data were examined for 
presence of outliers, which identified several extreme values across variables of interest. 
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These values were excluded from all analyses because of their potential for skewing 
measures of central tendency and introducing systematic error on variables of interest.  
Non-directional hypotheses were tested using two-tailed tests.  The criterion for statistical 
significance was p < .05 unless otherwise noted.   
3.2 Characteristics of the samples 
3.2.1 Demographics Comparison 
A series of independent-samples t-tests were conducted to examine demographic 
differences between the two groups. The MS sample and the HC samples did not differ 
significantly on age (t(54) = 0.44, p = .664), education (t(45) = 0.61, p = .545), or work 
status (full time versus unemployed or part time; χ2(1, N = 47) = 0.01, p = .905). The 
groups differed significantly on racial distribution (χ2(2, N = 47)  = 6.66, p = .036); see 
section 2.2.2 (General demographics) for a description of the racial distribution of the 
samples. 
3.2.2 Clinical characteristics 
Verified by records from their treating neurologist, 92.6% (n = 25) of participants 
had a confirmed diagnosis of Relapsing Remitting MS disease type, and 7.4% (n = 2) 
were diagnosed with Secondary Progressive MS disease type.  Average disease severity 
(negative values = more impairment) as measured with the MSFC was 0.05 (SD = .62) 
for the MS group and .47 (SD = .47) for the HC group; these values were statistically 
significantly different, t(43) = 2.49, p = .028. In the MS group, participants had been 
diagnosed with MS for an average of 9.81 years (SD = 8.32), had experienced symptom 
onset an average of 15.44 years ago (SD = 10.46), and were on a stable regimen of 
medications at the time of the study.  
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3.2.3 Psychosocial outcome measures 
Depression symptoms were measured with the BDI-II.  The average BDI-II score 
was 14.15 (SD = 10.20) in the MS group and 4.30 (SD = 4.77) in the HC group, a 
statistically significant difference, t(45) = 4.00, p < .001.  Average level of reported 
fatigue interference with daily functioning, as reported on the Fatigue Severity Scale 
(FSS), was 4.09 (SD = 2.01) in the MS group and 2.43 (SD = .92) in the HC group, a 
statistically significant difference, t(44) = 3.361, p = .002.  Overall quality of life as 
measured by MSQOL-54 Overall QoL was 65.93 (SD = 22.47) in the MS group and 
79.83 (SD = 13.7) in the HC group, a statistically significant difference, t(43) = 2.36, p = 
.023.  Thus, as expected, group differences were identified on measures of symptom 
severity, depression, fatigue, and quality of life, and therefore these variables will be used 
as covariates or entered in the first block of stepwise regressions in subsequent analyses. 
3.3 Results of Aim 1  
 In general, Aim 1 focused on identifying between-group differences (MS versus 
HC) on several measures of PM function, controlling for the psychosocial and symptom 
severity variables described above. Additional exploratory analyses were also conducted; 
these additional analyses, which included within-group statistics (stepwise linear 
regressions) on each of the groups separately, were employed with the goal of 
investigating what factors predict objectively- and subjectively-measured PM function in 
the MS and HC samples. Because one of the study’s overarching aims was to examine 
whether any of several aspects of PM (such as component processes or PM errors) differ 
in the MS population as compared to the healthy population, a comparison of the factors 
impacting PM in these two samples is of particular interest to the current analysis. 
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3.3.1 Hypothesis 1: Individuals with MS perform more poorly on objective tests of 
PM than healthy controls. 
MIST. Descriptive statistics for overall objective PM measures are summarized in 
Table 3.  Where possible, raw scores were converted to age- and education-standardized 
scores to facilitate comparisons between tests. Results of ANCOVA on age- and 
education-standardized scores on the MIST (PMT%) did not reveal a significant effect of 
group on MIST performance, F(5,35) = 2.009, p = .102, observed power = .60. To 
examine within-group differences, stepwise multiple linear regression analyses were 
performed on each group separately, using MIST PMT% as the dependent variable and 
demographic (age, education), psychosocial (BDI-II, FSS Average Score, 3 MSQoL-54 
Summary Scores), disease severity (MSFC Score), and PM variables (PMCQ Total Aids 
used, CPM Task Plan, Recall, Initiation, and Execution scores) were entered as predictor 
variables. Regressions revealed that in the MS group, MIST performance was 
significantly predicted by a model containing CPM Plan Score, CPM Execution Score, 
number of PM aids reported, and BDI-II Score, and the model explained 68.7% of the 
variance in MIST PMT%, F(4,16) = 8.773, p = .001, R2 = .687. The regression model’s 
beta values revealed CPM Plan Score (β = 0.76, p = .001), BDI-II Score (β = -0.53, p = 
.002), PM aids reported (β = 0.53, p = .004), and CPM Execution Score (β = -0.43, p = 
.048) to be significant predictors of MIST PMT%. 
In the HC group, MIST performance was significantly predicted by a model 
containing CPM Initiation Score, CPM Recall Score, age, and number of PM aids 
reported, and the model explained 71.8% of the variance in MIST PMT%, F(4,11) = 
10.562, p = .001, R2 = .718. The regression model’s beta values revealed age (β = 0.48, p 
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= .008), PM aids reported (β = -0.40, p = .015), CPM Recall Score (β = 0.37, p = .024), 
and CPM Initiation Score (β = 0.35, p = .033) to be significant predictors of MIST 
PMT%. In summary, there were no significant group differences on MIST total score, 
and distinct variables predicted MIST total score for each of the groups: [CPM Plan 
Score + BDI-II score + number of PM aids reported + CPM Execution Score ] in the MS 
group and [Age + number of PM aids reported + CPM Recall Score + CPM Initiation 
Score] in the HC group. 
 
Table 3. Objective PM Measure Scores 
Measure MS Group HC Group Effect 
Size (d)  M SD M SD 
MIST PM Total Score (Raw) 40.27 6.89 41.7 5.67 0.228 
MIST PM Total Score (%ile) 61.5 29.96 65.5 29.27 0.135 
CPM task Plan score 8.36 4.31 9.30 3.87 0.230 
CPM task Recall score 8.56 3.87 9.25 4.77 0.160 
CPM task Initiation score 1.65 0.48 1.58 0.75 0.114 
CPM task Execution score 3.29 1.00 3.69 0.48 0.541 
 
 
 
Complex Prospective Memory (CPM) Task. Analyses of the CPM task were 
completed for all four task variables (Plan, Recall, Initiation, and Execution). Results of 
ANCOVA of scores on all four variables did not reveal any significant group differences 
on any of the CPM variables when controlling for BDI-II score, FSS Average Score, 
MSFC score and MSQoL-54 overall QoL score. Follow-up stepwise multiple linear 
regression analyses were then performed identically to those above but removing CPM 
task variables as predictors.  
For CPM Plan Score, regressions revealed that in either group, none of the 
predictor variables significantly predicted CPM Plan Score.  
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For CPM Recall Score, regression revealed that in the MS group, none of the 
predictor variables significantly predicted CPM task Recall Score. In the HC group, CPM 
Recall Score was significantly predicted by a model containing MSQoL-54 Physical 
Composite score, and the model explained 31.3% of the variance in CPM Recall Score, 
F(1,14) = 6.385, p = .024, R2 = .313. The regression model’s beta values revealed 
MSQol-54 Physical Composite score (β = -0.56, p = .024) to be a significant predictor of 
CPM Recall Score. 
For CPM Initiation Score, regressions revealed that in in either group, none of the 
predictor variables significantly predicted CPM Initiation Score. 
For CPM Execution Score, regression revealed that in the MS group, CPM 
Execution Score was significantly predicted by a model containing level of education, 
and the model explained 33.9% of the variance in CPM Execution Score, F(1,22) = 
11.262, p = .003, R2 = . 339. The regression model’s beta values revealed education (β = -
0.58, p = .003) to be a significant predictor of CPM Execution Score. In the HC group, 
none of the predictor variables significantly predicted CPM Execution Score. 
In summary, there were no significant group differences on CPM Plan, CPM 
Recall, CPM Initiation, or CPM Execution Scores. In the MS group, CPM Execution 
Score was predicted by education level. In the HC group, CPM Recall Score was 
predicted by MSQoL-54 Physical Composite Score. 
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3.3.2 Hypothesis 2: Individuals with MS self-report committing more subjective 
PM errors than healthy controls. 
 PMCQ. Descriptive statistics for subjective PM measures are summarized in 
Table 4. Results of ANCOVA of Frequency Scale scores on the PMCQ did not reveal a 
significant effect of group on PM problem frequency, F(5,34) = 1.011, p = .427. To 
examine within-group differences, stepwise multiple linear regression analyses were 
performed on each group separately, using PMCQ Frequency Score as the dependent 
variable and demographic (age, education), psychosocial (BDI-II, FSS Average Score, 3 
MSQoL Summary Scores), disease severity (MSFC Score), and PM variables (PMCQ 
Total Aids used, CPM Task Plan, Recall, Initiation, and Execution Scores) were entered 
as predictor variables. Regressions revealed that in the MS group, self-reported frequency 
of PM errors was significantly predicted by a model containing CPM Recall Score, and 
the model explained 33.7% of the variance in PMCQ Frequency Score, F(1,20) = 10.172, 
p = .005, R2 = .337. The regression model’s beta values revealed CPM Recall Score (β = 
0.58, p = .005) to be a significant predictor of PMCQ Frequency Score. In the HC group, 
none of the predictor variables significantly predicted PM problem frequency. In 
summary, there were no significant group differences self-reported PM error Frequency 
Score, and in the MS group, PMCQ Frequency Score was predicted by CPM Recall 
Score, but no significant predictors emerged in the HC group. 
 
 
 
 
37  
Table 4. Subjective PM Measure (PMCQ) Scores 
Measure MS Group HC Group Effect Size 
(d)  M SD M SD 
Summary Variables      
    Total Items Answered** 22.19 2.47 19.78 2.37 0.996 
    Frequency Scale Score 0.39 0.16 0.37 0.19 0.114 
    Distress Scale Score 0.36 0.31 0.41 0.34 0.154 
Stage Sub-Score Variables      
    Plan Stage 2.59 1.89 2.67 1.71 0.044 
    Recall Stage* 1.26 1.63 0.39 0.70 0.747 
    Initiation Stage 3.44 1.93 3.11 1.88 0.173 
Domain Sub-Score Variables      
    Medical Domain* 2.56 3.40 0.72 1.18 0.803 
    Vocational Domain 3.89 3.98 2.89 3.53 0.266 
    Social Domain 2.96 2.14 3.28 3.39 0.116 
    Everyday Activities Domain 7.19 4.15 8.06 4.93 0.192 
** = significantly different at Bonferroni-corrected p < .004 
* = significantly different at p < .05 
 
3.3.3 Hypothesis 3: Individuals with MS self-report experiencing more subjective 
distress related to PM errors than healthy controls. 
Results of ANCOVA on Distress Scale scores on the PMCQ did not reveal a 
significant effect of group on PM problem distress, F(5,34) = 0.477, p = .791. To 
examine within-group differences, stepwise multiple linear regression analyses were 
performed on each group separately, using PMCQ Distress Score as the dependent 
variable and demographic (age, education), psychosocial (BDI-II, FSS Average Score, 
MSQoL Summary Scores), disease severity (MSFC Score), and PM variables (PMCQ 
Total Aids used, CPM Task Plan, Recall, Initiation, and Execution Scores) were entered 
as predictor variables. Regressions revealed that in the MS group, distress related to self-
reported PM errors was significantly predicted by a model containing CPM Recall Score, 
and the model explained 33.3.% of the variance in PMCQ Distress Score, F(1,20) = 
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9.989, p = .005, R2 = .333. The regression model’s beta values revealed CPM Recall 
Score (β = 0.58, p = .005) to be a significant predictor of PMCQ Distress Score. In the 
HC group, none of the predictor variables significantly predicted PM problem distress. In 
summary, there were no significant group differences in self-reported PM error Distress 
Score, and in the MS group, PMCQ Distress Score was predicted by CPM Recall Score, 
but no significant predictors emerged in the HC group. 
3.3.4 Hypothesis 4: Individuals with MS self-report a different pattern of PM 
Stage errors than healthy controls.  
As an exploratory analysis, a series of Bonferroni-corrected independent-samples 
t-tests were conducted on the remaining PMCQ variables: the Stage Sub-Score variables 
(Plan stage, Recall stage, and Initiation stage), the Domain Sub-Score variables (Medical, 
Vocational, Social, and Everyday Activities domains), total items answered (i.e., NOT 
rated “N/A”) and reported number of PM aids used. Results revealed significant 
differences between the MS and HC groups for only total items answered at the 
Bonferroni-corrected significance level (p < .004), t(43) = 3.260, p = .002, d = 0.996. 
Two other variables did not reach this level of significance but were significantly 
different at the p < .05 level: Recall Stage score, t(43) = 2.131, p = .039, d = 0.747; and 
Medical Domain score, t(43) = 2.194, p = .034, d = 0.803. In summary, compared on all 
PMCQ scales, the groups only differed significantly on the total number of PMCQ items 
they endorsed, with MS participants endorsing a significantly higher proportion of 
PMCQ items than HCs. Potential trends (i.e., group differences significant at p = .05) on 
endorsements of Recall Stage errors and Medical Domain errors revealed that MS 
participants may have reported more errors occurring in the Recall stage of PM (e.g., “I 
39  
forgot some important detail about the PM task”) and may have reported more PM errors 
on medically-related PMCQ items (e.g., missing a doctor’s appointment or medication 
regimen errors).  
3.4 Results of Aim 2 
3.4.1 Hypothesis 5: Analysis of PMCQ as a measure of PM function 
 The utility of the PMCQ as a measure of PM function was examined both 
quantitatively (i.e., correlation with objective PM measures) and qualitatively (i.e., 
collective user feedback).  
Quantitative analysis. Correlation analyses were performed to examine 
associations between PMCQ variables and objective measures of PM (MIST scores and 
CPM task scores). Significant correlations between PMCQ scores and objective measures 
are presented in Table 5. Of note, no PMCQ variables were correlated with any MIST 
variables. In summary, the strongest correlations were observed between the Vocational 
Domain Sub-score on the PMCQ and CPM Plan Score, and between the Social Domain 
Sub-score of the PMCQ and CPM Recall Score. 
 
Table 5. Correlations between PMCQ Scores and Objective PM Scores 
Measure 1 Measure 2 Pearson’s 
r value 
p-
value 
PMCQ Frequency Score CPM Plan Score .309 .044 
PMCQ Frequency Score CPM Recall Score .320 .036 
PMCQ Distress Score CPM Recall Score .339 .026 
PMCQ Initiation Score CPM Plan Score .304 .047 
PMCQ Initiation Score CPM Recall Score .319 .037 
PMCQ Voc. Domain Score CPM Plan Score .418 .005 
PMCQ Social Domain Score CPM Plan Score .334 .029 
PMCQ Social Domain Score CPM Recall Score .368 .015 
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 Because a secondary PMCQ variable (number of PM aids reported) was a 
significant predictor of MIST performance in both groups, exploratory analyses were 
conducted to examine correlations between this variable and MIST supplementary scale 
scores. In the MS group, the strongest correlation (r = .53, p = .009) was identified 
between aids reported and MIST Recognition Memory Percentile. In the HC group, the 
strongest correlation (r = -.66, p = .003) was identified between aids reported and MIST 
Verbal Response Percentile. 
To examine reliability of the questionnaire using internal consistency, Cronbach’s 
Alpha (α) was computed for the set of all 25 PMCQ items, and for each set of items 
comprising the four domain sub-scales. Only the Frequency scale data were used, 
because of the inability of the α method to process missing data points. Overall, the 
PMCQ was found to be highly internally consistent (25 items; α = .94). The Medical 
Domain subscale consisted of 4 items (α = .60), the Vocational Domain subscale 
consisted of 6 items (α = .79), the Social Domain subscale consisted of 6 items (α = .20), 
and the Everyday Activities Domain subscale consisted of 9 items (α = .65). Overall, the 
PMCQ appears to demonstrate strong reliability, except for the Social Domain scale. 
Follow-up analyses suggest that several specific items should be removed from the 
questionnaire (most notably, items 14 and 22, which contributed no variance). 
Qualitative Analysis. Based on user feedback, tentative conclusions can be made 
about the PMCQ measure. Several items were not endorsed by many participants, and 
were noted to probably be obsolete. The fact that individuals with a chronic disease like 
MS have more medically-related tasks to which they need to attend compared to healthy 
individuals was pointed out by several participants, and thus it is expected that different 
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patterns of item endorsement would be observed across medical and non-medical 
populations, and likely also across different disease populations. Additionally, many of 
the individuals with MS indicated that before their diagnosis and/or before significant 
disease progression, they would have had many other obligations which would have 
increased their prospective memory task load (e.g., more work-related PM demands 
before their disease forced them out of work). It was also indicated by many MS 
participants that they had intentionally reduced their potential PM demands because of 
concerns about cognitive dysfunction. Both of these factors would be reflected by 
potentially lower scores on the PMCQ despite significant PM problems in associated 
domains.  
 
4. DISCUSSION 
This study sought to examine prospective memory function in individuals with 
multiple sclerosis as compared to healthy controls.  Specific goals were to initiate a 
theoretically-based approach to examining PM in the MS population, and to examine the 
utility of a standardized objective measure of PM (the Memory for Intentions Test 
(MIST)), an experimental PM paradigm (the Complex Prospective Memory (CPM) task) 
and a novel subjective measure of PM (the Prospective Memory Complaints 
Questionnaire (PMCQ)) for understanding PM difficulties in individuals with MS as 
compared to healthy individuals. Additionally, the study sought to collect user feedback 
to begin to validate the PMCQ as a measure of self-reported PM difficulties. Impaired 
PM function in individuals with MS has been reported in the literature in very few 
empirical studies to date (Kardiasmenos, Clawson, Wilken, & Wallin, 2008; Rendell, 
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Jensen, & Henry, 2007; Bravin, Kinsella, Ong, & Vowels, 2000). However, the current 
study’s employment of a theoretical model of PM, the Multiphasic Process model, 
permitted the current analyses to take into account the reasons for PM errors, rather than 
simply examine the incidence of errors in a binary fashion. 
4.1 Main Findings 
MIST. Contrary to hypotheses, and despite statistically controlling for symptom 
severity, depression, fatigue symptoms, and quality of life variables, no significant 
differences were identified in objective, age- and education-normed PM ability (i.e., 
overall MIST performance). Our analyses identified disparate patterns of factors related 
to PM ability in each sample. For the control group, performance on PM recall and 
initiation, as well as age and reported number of PM aids used predicted MIST 
performance. In contrast, for the MS sample, MIST performance was predicted by 
depression level, PM planning ability, PM task execution (i.e., the actual mSET task), 
and reported number of PM aids used.  Interestingly, while total reported PM aids used 
was related to objective PM ability in both groups, the prediction occurred in the opposite 
direction for each group. One way to interpret this finding is that healthy participants 
demonstrated awareness of their PM ability, as those that reported needing more help 
completing PM tasks in their everyday lives (e.g., post-it notes, calendars or asking for 
help) performed more poorly on the MIST. Conversely, individuals with MS 
demonstrated a lack of this awareness, as those that reported using fewer PM aids 
performed more poorly on the MIST. However, this interpretation assumes that self-
reported number of aids used is a suitable measure of one’s awareness of PM deficits. 
While this PMCQ item may tap into this phenomenon to some degree, the manner in 
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which the item is presented introduces several confounds. For one, it does not query the 
total number of aids used but the number of types of aids used; thus, no data is available 
about the degree (e.g., frequency) one uses aids such as datebooks or sticky notes. 
Secondly, the options this item provides conflate internally-mediated aids (e.g., mental 
rehearsal) with externally-mediated aids (e.g., electronic reminders). Thus, use of this 
variable as a predictor of PM ability is somewhat flawed and difficult to interpret. 
Secondary analyses explored correlations between this variable and other variables of 
interest within each group. The strongest relationships were seen between aids reported 
and recognition memory on the MIST (+ relationship) in the MS group and between aids 
reported and verbal-item performance on the MIST (- relationship) in the HC group; 
these findings indicate that the relationships described above may be mediated by 
recognition memory ability (in the MS group) and memory for verbal PM information (in 
the HC group). Again, these findings are very preliminary and difficult to interpret 
without context. 
The result that older HCs demonstrated better MIST performance may reflect a 
phenomenon often observed in the literature dubbed the “age prospective memory 
paradox,” wherein older adults perform better than younger adults on more naturalistic 
PM tasks (Bailey, Henry, Rendell, Phillips, & Kliegel, 2010). Thus, this finding is 
counterintuitive but not entirely unexpected. In addition to these factors, PM recall and 
initiation abilities also predicted MIST performance in the HC group, demonstrating 
retrospective memory and ability to actually initiate a task at the correct time (in response 
to a cue, in this case) as significant factors related to overall PM function in this group. 
By contrast, in the MS group, depression level, PM planning and execution abilities were 
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significant predictors of MIST performance. The PM task execution results actually 
revealed that, after controlling for CPM Plan Score, BDI-II Score, and number of PM 
aids reported, participants that scored higher on the CPM Execution task (the mSET) 
performed more poorly on the MIST; this finding is difficult to interpret and may be 
spurious. Of note, PM planning ability was the strongest identified predictor in this 
group.  
Overall, the findings in the MS group appear to indicate that in the MS sample, 
ability to plan an intention was a better predictor of PM performance than retrospective 
memory or the ability to initiate correctly in response to a cue. One hypothesis is that, in 
the healthy population, the “intention formation” stage happens automatically without 
much cognitive control, and thus retaining the intention details and detecting the cue 
correctly are more significant processes, while in MS the ability to formulate an intention 
adequately requires more conscious processing, and individuals with even subtle 
cognitive deficits cannot rely on their retrospective memory and initiation (e.g., attention-
switching) abilities alone to help them successfully complete PM tasks. This hypothesis 
is partly supported by previous literature that demonstrates processing speed deficits in 
MS (Bruce et al., 2010) as well as the importance of processing speed to PM planning 
abilities (Kliegel, Jager, Altgassen, & Shum, 2008; West & Craik, 2001); however, it is 
still extremely preliminary.  
 These findings suggest that future studies would benefit from including measures 
of neuropsychological constructs that may impact PM ability or individual stages of 
processing, such as information processing speed or set-shifting capacity. Such 
investigations could shed light on which constructs are actually essential (or supportive) 
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to PM function, and provide context for the current study’s interesting but complex 
findings. It is possible that the Multi-Phasic Process model of PM simply does not apply 
to individuals with MS as it does with other populations, and thus future investigations 
should explore this possibility as well. The finding that depression score predicted 
objective PM performance on the MIST is intriguing, but it is difficult to identify the 
mechanism of action of such an association. Perhaps depressed individuals with MS 
simply have more on their minds and thus fewer cognitive resources to devote to PM 
tasks, even in the laboratory. 
Complex Prospective Memory (CPM) Task. The other objective measure of PM 
function used in this study, the CPM task using the modified Six Elements Task, revealed 
similar patterns to those identified with the MIST. No overall group differences were 
identified for any of the four stages of the task (Plan, Recall, Initiation or Execution). 
Overall, few variables significantly predicted performance on these tasks in either group. 
In the HC group, the only significant prediction occurred for PM recall performance, 
which was predicted only by self-reported physical disability factors identified on a 
quality of life measure, such that those reporting more physical disability performed more 
poorly on recall of their CPM plan. This finding is difficult to interpret and may be 
spurious. In the MS group, the only variable that predicted PM task execution was 
education level, such that higher educational attainment was associated with better scores 
on this measure (the mSET).  
 Overall, performance on objective measures of PM function in the MS and HC 
groups revealed several interesting patterns and indicated that the intention formation 
stage may be particularly important to PM task success in individuals with MS, but that 
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healthy individuals may be able to rely on their recognition memory or executive 
functions (e.g., attention-shifting or cue detection/vigilance) to successfully complete PM 
tasks. However, additional research will be required to further explore these hypotheses.  
PMCQ. Although novel, the PMCQ permitted examination of several aspects of 
PM function. In the current study, group comparisons of subjectively-reported PM errors 
failed to identify group differences in PM error frequency as measured by the PMCQ, 
even when controlling for symptom severity, depression, fatigue, and quality of life 
variables. When examined separately, the MS group’s performance demonstrated that 
PM recall ability alone predicted frequency of self-reported PM errors such that as recall 
performance increased, frequency of reported errors increased. While counterintuitive, 
this finding may indicate that individuals with MS with better retrospective memory 
ability are more accurately able to report on their PM errors than those with poorer 
retrospective memory. In the HC group, none of the proposed factors predicted self-
reported PM error frequency, which may be a result of a restricted range of performance 
on many study variables in this sample. Regardless, these results did not indicate that 
individuals with MS experience more frequent self-reported PM errors than healthy 
individuals, and thus Hypothesis 3 was not supported. 
Overall, group comparisons revealed that there were no differences in 
subjectively-reported distress related to PM errors between the samples. Within the 
groups separately, self-reported PM-error distress showed an identical pattern to 
Frequency scale analyses in both groups (see discussion above), which may indicate that 
these two scales tap into the same behavioral phenomenon and thus share variance. This 
may indicate that querying the level of distress experienced during PM errors does not 
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offer much additional information above and beyond querying error frequency alone; 
conversely, it could demonstrate that individuals experiencing more subjective distress 
report more frequent cognitive problems. Further research is needed to elucidate this 
relationship. 
Secondary analyses of PMCQ sub-scale variables were conducted to examine 
group differences on variables such as total PMCQ items endorsed, reported PM aids 
used, and Stage and Domain sub-scores. Significant group differences were identified 
only for total PMCQ items endorsed (i.e., total number of queried PM tasks that were 
applicable to the participant and not rated “N/A”), such that individuals with MS reported 
engaging in more of the PM tasks presented in the questionnaire than did HC individuals. 
This likely reflects the greater number of medically-related PM tasks required of 
individuals with a chronic disease (and this conclusion is partially supported by analysis 
of the Medical Domain sub-scores, which revealed a trend, with a large effect size, 
signifying that MS participants may have reported more errors on medically-related 
items), but is interesting in light of the feedback of several MS participants indicating 
reduced everyday PM demands because of not working, reduced social engagements, 
among other factors. While very preliminary, this finding is important, as it indicates that 
PM demands are a significant aspect of the lives of those living with MS, perhaps even to 
a greater degree than those in the normal population. While not statistically significant at 
the Bonferroni-corrected level, the finding that individuals with MS may have reported 
more retrospective memory-related PM errors than healthy individuals may represent a 
greater concern with cognitive abilities, particularly memory problems, in the MS 
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population than in the healthy population (Shevil & Finlayson, 2006). Of note, this group 
difference exhibited a medium-to-large effect size.  
One of the main aims of the current study was to assess the utility of the PMCQ 
as a measure of PM function in the MS population and controls. A promising finding 
emerged in that the PMCQ was found to be highly internally consistent, and each of the 
Domain Sub-scales (except for the Social Domain) demonstrated strong reliability 
characteristics. On the other hand, while providing much data about subjective PM 
concerns, the PMCQ was not found to be highly associated with objective PM 
performance or even corresponding PM component stages, at least as measured on the 
MIST and the CPM task. Perhaps due to inadequate statistical power, the Stage sub-
scales of the PMCQ were not reliably associated with performance on objective PM 
stages of planning, recall, and initiation. Thus, the PMCQ was not supported as a valid 
way to assess component stages of the PM process in either individuals with MS or 
healthy individuals. There are several possible explanations for this finding, including a) 
that either the PMCQ, the MIST, the CPM task, or some combination of these measures 
was not sensitive enough to detect PM impairments in these high-functioning groups; b) 
if PM impairments were present in either group, both PM function and self-report of it 
were both compromised enough to obscure patterns; or c) the PMCQ or the Multi-Phasic 
Process model itself is flawed and is not a valid way to examine real-world PM function. 
Unfortunately, the data collected in this study cannot fully tease these possibilities apart. 
Several of these hypotheses will be addressed in subsequent sections. 
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4.2 Prospective Memory in Multiple Sclerosis 
 One of the immediate questions raised by these data concerns the lack of 
replication of previous research. Clearly, the current study’s negative findings with 
regard to objective PM differences between MS and HC groups is at odds with several 
prior research studies, which did identify PM impairments in MS. Bravin et al. (2000) 
conducted the first study of PM in MS with a considerably less educated sample than that 
of the current study (Mean education = 11.2 years compared to 15.2 years in the current 
sample), and found that PM differences between the groups, identified using 
nonparametric statistics, were driven nearly entirely by retrospective memory deficits. In 
the only two other studies examining PM in MS specifically (Kardiasmenos, Clawson, 
Wilken, & Wallin, 2008; Rendell, Jensen, & Henry, 2007), the same PM measurement 
methodology (the Virtual Week board game task) was used, and impairments were 
identified in the MS groups compared to control groups. The MS samples in these studies 
appeared to be more closely matched to the current sample’s demographic characteristics. 
Interestingly, the latter study demonstrated that initiating a specific planning strategy 
(implementation intentions) increased the performance of the MS group nearly to that of 
controls on more difficult PM subtasks; this effect lends support to our finding that the 
planning stage in particular is related to overall PM task success in MS. One other study 
(Bruce et al., 2010) did not utilize a control group and made use of an outdated version of 
the MIST, and thus it is difficult to put PM performance results in any useful context.  
With these previous studies in mind, several explanations are possible for the 
current study’s inability to identify objective PM differences between the MS and HC 
groups. Perhaps the most likely explanation is that the MIST (as opposed to the Virtual 
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Week) is not a sensitive enough measure to capture PM impairments in a high 
functioning sample such as the current MS group. The fact that, on average, both the MS 
and HC groups performed well on the MIST (percentiles = 61.5 and 65.5, respectively) 
lends support to this possibility, and begs the question of whether this issue may have 
been present in the data collected on the PMCQ and the CPM task as well. On the other 
hand, the Virtual Week, which is the basis for nearly all of the current conclusions about 
PM deficits in MS, may be systematically biased against individuals with MS in some 
way that is not a direct result of PM function deficits. Some authors have criticized the 
associative learning aspects that half of the tasks require (Hadjiefthyvoulou, Fisk, 
Montgomery, & Bridges, 2011). Associative learning deficits have been identified in MS 
(Basso, Lowery, Ghormley, Combs, & Johnson, 2006), and thus may confound the use of 
this measure in individuals with MS.  Another problem with the Virtual Week is that 
nearly every investigation following Rendell & Craik’s (2000) original use of the task has 
used a “modified” version, and modifications are often significant (e.g., computerized 
version rather than actual board game; Rendell, Phillips, Henry, Brumby-Rendell, de la 
Piedad Garcia, Altgassen, & Kliegel, 2011).Though the Virtual Week has been shown to 
be sensitive to PM deficits in aging and psychiatric populations (Rendell, Jensen, & 
Henry, 2007), more research should be conducted with this measure in concordance with 
other PM measures, particularly in MS, and further investigation of cognitive correlates 
of Virtual Week performance should be conducted as well. Overall, these issues signify 
the need for more sensitive measures (and models) of PM to detect subtle PM 
impairments which may nevertheless be behaviorally significant.   
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 4.3 Remaining Questions Regarding Measurement of PM in MS 
 One of the questions the current study set out to answer was a fundamental one: 
How does one measure prospective memory function in MS? Unfortunately, the findings 
did not provide a conclusive answer, likely because of either a) sample characteristics 
(e.g., no actual PM deficits present in our sample), b) measure characteristics (e.g., 
measures were not sensitive enough to detect subtle impairments), or c) both (a) and (b). 
One of the major reasons to measure PM in patient populations is its relevance to 
everyday function, as well as the fact that PM errors may be significant even in less 
impaired populations (Kliegel, Jager, Altgassen, & Shum, 2008). It is possible that subtle 
real-world PM problems are so inseparable from their contexts that they cannot be 
measured with standardized objective measures; if so, self- or informant-report may be 
the only valid way to measure them. On the other hand, perhaps measuring stages of PM 
processing individually (e.g., “PM planning,” à la the Multi-Phasic Process model), each 
as they relate to overall PM task performance (and thus NOT merely as distinct 
neuropsychological phenomena) could prove to be a useful way to examine PM in 
different patient populations, especially if particular deficits were identified as 
characteristic of different disorders (e.g., Kliegel, Eschen, & Thöne-Otto, 2004). 
 In light of previous literature, it was not wholly unexpected that subjectively-
reported PM ability did not correlate well with objective, standardized PM assessment 
(e.g., Bruce, Bruce, Hancock, & Lynch, 2010). However, it is still worthwhile to consider 
why this relationship was not more robust. While the MIST is able, at least in theory, to 
tease apart many significant aspects of PM (e.g., time vs. event cueing, long and short 
delays), the theoretical basis on which it was developed may simply be too different from 
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the theoretical model utilized in this study, the Multi-Phasic Process model. The current 
study’s objective measure of PM stages, the CPM task, also did not show robust 
correlations between corresponding objective PM stage scores and self-reported PM stage 
errors on the PMCQ, which is likely a result of the “unrefined” nature of both measures, 
which have thus far been used infrequently (or not at all, in the case of the PMCQ). It is 
encouraging, however, that several PMCQ scales, such as the vocational and social 
domain scales did correlate with objectively-measured PM stages (i.e., the plan and recall 
stages of the CPM). It is worth noting that even thoroughly-studied neuropsychological 
constructs often do not show strong relationships across measurement methods (i.e., 
objective versus subjective), which is not surprising for constructs such as retrospective 
memory, for obvious reasons. Prospective memory is likely to be even more complex and 
is definitely not as well understood, and thus preliminary inquiries like the current study 
are needed to determine what aspects of PM are more and less accessible to different 
measurement methods. As of now, clinicians should use caution when interpreting either 
type of measure, as performance-based measures of PM may not yet be sensitive enough 
to detect subtle or context-dependent PM impairments, and self-report measures of PM 
may be confounded by the impairments themselves (Thone-Otto & Walthier, 2008; 
Marrie et al., 2003). 
4.4 Limitations 
Several limitations to the current study deserve consideration. Though sample 
sizes in each group met (or nearly met, in the HC group) target sample sizes predicted by 
power analyses, power to detect differences on many of the measures used in this study 
was limited by a small sample size. Though medium and large effect sizes are reported in 
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the literature for the effects of MS diagnosis on PM ability (Kardiasmenos et al., 2008; 
Rendell et al., 2007; Bravin et al., 2000), PM deficits (if they existed) in our sample of 
MS participants were too subtle to be discerned by the measures utilized. Notably, our 
sample of individuals with MS was relatively high-functioning, and it may be that an 
increase in sample size and range of impairment would have allowed significant 
differences to emerge. However, an advantage of having a high-functioning clinical 
population is the ability to examine subtle cognitive phenomena, and the MS population 
in particular was chosen in this study because of their significant engagement and often 
intact cognitive functioning, as measured by traditional neuropsychological variables. In 
general, the conclusions generated from this study may be limited to the current high-
functioning sample of individuals with MS, and multiple aspects of PM function may 
differ in individuals with MS with varying levels of cognitive, physical or other 
impairment. Other limitations to this study are largely related to the exploratory nature of 
the research itself, in that the study was limited by the use of: a) a new measure of PM 
function, the PMCQ; b) a model of PM, the Multi-Phasic Process (MPP) model, that has 
not yet been fully validated; and c) an experimental (and thus also not fully validated) 
PM paradigm, the CPM task. While an exploration of subjective (PMCQ) and objective 
(CPM task) measures of PM informed by a theoretical model (the MPP model) was the 
overarching goal of this study, such an exploration provides little empirical basis to put 
findings in context.  
4.5 Strengths 
On the other hand, several strengths of this study arose from its exploratory 
nature. Because the study controlled for so many psychosocial variables (e.g., depression, 
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quality of life, fatigue, demographic variables) that have been found to be important in 
the MS population, conclusions could be drawn about the impact, or lack thereof, of these 
variables on PM ability in both the MS and HC samples. Thus, while depression did 
predict scores on self-report inventories and on the MIST in the MS group, neither 
symptom severity, fatigue, quality of life, nor demographic variables such as age or 
education level were able to significantly predict objective PM performance in 
individuals with MS, demonstrating the independence of these psychosocial constructs 
from PM function in this population. Many of the questions raised by this study about the 
use of the MPP model, the MIST, the CPM task, and self-reported PM difficulties (e.g., 
whether these theories or measures are applicable to this population in the same ways as 
in the normal population) could not have been addressed as broadly in a more rigidly 
structured study. Likewise, external validity of findings is likely enhanced by the use of 
both objective and subjective measures, and internal validity was enhanced by the use of 
such a well-matched control group. The PM literature (Thone-Otto & Walthier, 2008) has 
identified the necessity of using both performance-based and self-report measures of PM 
ability because of the complexity and real-world applicability of PM, and while this study 
did not identify particularly high correlations between these two types of measures, it did 
not refute this association either, but demonstrated the possible utility of either type of 
assessment independently. 
4.6 Future Directions   
 The current study provided a set of new research questions and indicated the 
necessity of further study of PM in MS in general. The Multi-Phasic Process model of 
PM, while intuitively constructed, is still in the early stages of empirical validation in the 
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literature, and it should continue to be fine-tuned with respect to the relative importance 
and operational definition of each stage in the process. This study points to the need for 
better variable specifications within clinical populations, even those with only subtle 
cognitive impairments, and perhaps most importantly, better measures of performance for 
each proposed PM stage. There is clearly room for measure development using both 
objective and subjective means, especially with regard to sensitivity to subtle PM deficits, 
which are complex and elusive. Closely related to this need is the need for more 
neuropsychological explorations of the component cognitive constructs of PM, which are 
far from being fully understood. PM function should be examined in samples with greater 
variability in factors such as disease severity and cognitive function than were present in 
the current sample, as well as in more clinical populations. It may also be worthwhile to 
begin establishing a composite measure of PM that could be used to integrate both 
subjective and objective measurements. Such a composite could also give differential 
weight to distinct aspects of PM function (e.g., time- versus event-cued tasks or tasks 
with different intervening durations). Lastly, researchers should seek to examine the 
contributions of PM factors and abilities to functional outcomes, such as vocational 
success or social engagement. 
4.7 Conclusion 
 Overall, the current theoretically driven exploratory analysis of objective and 
subjective prospective memory difficulties in both individuals with and without multiple 
sclerosis identified discrepant predictors of PM performance between the groups, despite 
nonsignificant overall differences in performance when controlling for symptom severity, 
depression, symptomatic fatigue, and quality of life reports. While much further research 
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is needed before all of the complex factors impacting PM performance in the MS 
population are well understood, the utility of breaking PM down into hypothesized stages 
of processing was demonstrated, as was the utility of using both objective and subjective 
measures of PM. Ideally, further study can clarify the relationships detected in this study 
and provide guidelines for assessment and remediation of PM difficulties in MS, other 
clinical populations, and even the general populace.  
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